Anivive Lifesciences, Inc. — Form D

Anivive Lifesciences, Inc. of LONG BEACH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-12. The offering totals $44.3M, of which $44.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-08-12
• Form: D
• Accession: 0001567619-21-015137
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $44.3M
• Amount sold: $44.3M
• Investors: 78
• Date of first sale: 2021-07-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-409702

Issuer

• Name: Anivive Lifesciences, Inc.
• CIK: 0001877715
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 3250 AIRFLITE WAY, LONG BEACH, CA, 90807
• Phone: (833) 264-8483

Officers, directors & promoters (10)

More

• CIK 1877715 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search